XTX Topco’s BioCardia BCDA Stock Holding History

XTX Topco’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,270	Closed	-$29.4K	–	4154
2026 Q1	$29.4K	Buy	24,270 +7,980	+49%	+$9.98K	﹤0.01%	3458
2025 Q4	$20.4K	Buy	16,290 +113	+0.7%	+$153	﹤0.01%	3057
2025 Q3	$20.9K	Buy	+16,177	New	+$31.6K	﹤0.01%	2323

Other funds holding BCDA

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

XTX Topco's BCDA Position: Q2 2026 in Review

XTX Topco sold out of BioCardia (BCDA) in Q2 2026, closing a stake of 24,270 shares — an estimated $29.4K sold.

XTX Topco first reported a position in BCDA in Q3 2025 and held it in 3 quarters. The position peaked at $29.4K in Q1 2026. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

XTX Topco reported no remaining BioCardia position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 24,270 BioCardia shares in Q2 2026, an estimated $29.4K.
XTX Topco first reported a position in BioCardia in Q3 2025 and held it in 3 quarters.
XTX Topco's BioCardia position peaked at $29.4K in Q1 2026.
21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.